{"disease":{"id":"schizophrenia-disorganized","name":"schizophrenia disorganized"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01190254","title":"Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT01190267","title":"Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT06789471","title":"The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Ru-Shin Zhang","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}